Cellebrite DI Ltd. (CLBT)
Cellebrite DI Ltd. (CLBT) Q3 2025 Earnings Call Transcript
Cellebrite DI Ltd. ( CLBT ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Andrew Kramer - Vice President of Investor Relations Thomas Hogan - CEO & Director David Barter - Chief Financial Officer Marcus Jewell - Global Chief Revenue Officer Conference Call Participants Jeff Van Rhee - Craig-Hallum Capital Group LLC, Research Division Brian Essex - JPMorgan Chase & Co, Research Division Tomer Zilberman - BofA Securities, Research Division Louie Dipalma - William Blair & Company L.L.C.
Cellebrite DI Ltd. (CLBT) Q3 Earnings and Revenues Beat Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.13 per share.
Cellebrite DI Ltd. (CLBT) Q2 2025 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q2 2025 Earnings Call August 14, 2025 8:30 AM ET Company Participants Adam H.
Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.1 per share.
Cellebrite DI Ltd. (CLBT) Q1 2025 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen Armon - Chief Products and Technology Officer Conference Call Participants Tomer Zilberman - Bank of America Jeff Rhee - Craig-Hallum Mike Cikos - Needham Jonathan Ho - William Blair Shaul Eyal - TD Cowen Eric Martinuzzi - Lake Street Operator Welcome to the Cellebrite First Quarter 2025 Financial Results Conference Call.
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share.
After Plunging -17.61% in 4 Weeks, Here's Why the Trend Might Reverse for Cellebrite DI Ltd. (CLBT)
Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.
Is This Stock a Next-Gen Digital Forensics Leader?
In this video, Anand Chokkavelu, Travis Hoium, and Lou Whiteman discuss Cellebrite (CLBT -5.53%), a key player in digital forensics for law enforcement. They provide ratings and insights on its growth potential, management, and financials, helping you decide if this stock is a worthy investment.
Cellebrite DI Ltd. (CLBT) Q4 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen Armon - Chief Products and Technology Officer Conference Call Participants Shaul Eyal - TD Cowen Bhavin Shah - Deutsche Bank Eric Martinuzzi - Lake Street Charlotte Bedick - JPMorgan Jeff Rhee - Craig-Hallum Mike Cikos - Needham Tomer Zilberman - Bank of America Louie DiPalma - William Blair Operator Welcome to the Cellebrite Fourth Quarter and Full Year 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (CLBT) Q4 Earnings Meet Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate.
Cellebrite to Report Q4 Earnings: Here's What You Should Know
The surge in subscription filters is likely to have benefited CLBT's top line in the fourth quarter of 2024.
Cellebrite: Country-Wide US Adoption In The Public Sector Is Remarkable
Cellebrite DI LTD (CLBT) offers unique digital investigative solutions to governmental agencies, showing strong market position and 172% stock growth in the past year. CLBT's ambitious financial targets include 24% CAGR in ARR and 20% CAGR in total revenues by 2028, with significant margin improvements since 2022. Despite a potential short-term sell-off, CLBT's low short interest and international customer base, especially in high-growth markets, mitigate long-term risks.
